Female hormones increase risk of vision loss in rare genetic disease

Female hormones increase risk of vision loss in rare genetic disease

Girls with a rare genetic disorder caused by mutations in a gene known as Nf1 are much more likely to lose their vision than boys with mutations in the same gene. And now, researchers at Washington University School of Medicine in St. Louis believe they know why: Female sex hormones activate immune cells that damage the nerves necessary for vision.
Fricks enhance commitment to Olin Business School facilities

Fricks enhance commitment to Olin Business School facilities

Washington University Emeritus Trustee Robert Frick, BS ’60, MBA ’62, and his wife, Barbara, recently made a $2 million commitment to support Olin Business School. The popular second-floor commons area in Knight Hall will be named Robert and Barbara Frick Commons in recognition of their generosity.
WashU Expert: Cures Act a good start, but is it immediate enough?

WashU Expert: Cures Act a good start, but is it immediate enough?

The 21st Century Cures Act, sweeping mental health legislation passed this week by the U.S. Senate, will provide necessary funding to help those with mental illnesses if signed by President Obama, but should focus more on mental health outcomes of those suffering right now, says a mental health expert at Washington University in St. Louis.
Surgery can restore vision in patients with brain injuries

Surgery can restore vision in patients with brain injuries

Surgery can restore vision in patients who have suffered hemorrhaging in the eye after a traumatic brain injury, even if the operation doesn’t occur until several months after the injury, according to a small study from vision researchers at Washington University School of Medicine in St. Louis.
Gene linked to metabolism drives deadly brain cancer

Gene linked to metabolism drives deadly brain cancer

While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer. The pathway, known as the nicotinamide adenine dinucleotide (NAD+) pathway, is overactive in a deadly form of brain cancer known as glioblastoma, according to a study by researchers at Washington University School of Medicine in St. Louis.
View More Stories